Moreover, it was found in a postmortem AD patient that the expression of mRNA TGF-β1 was negatively correlated with the formation of NFT [85], suggesting impairment of TGF-β1/Smad signaling in tau pathology. This evidence concerns the gene TGFB1 and Alzheimer disease.